Japan Medical Dynamic Marketing, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
493.00
-342.00
1,636.00
1,769.00
2,749.00
2,034.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-776.00
-1,157.00
-302.00
-995.00
-430.00
-582.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
205.00
1,046.00
2,104.00
2,186.00
3,111.00
2,599.00
Cash Flow from Investing Activities
-1,995.00
-1,666.00
-1,804.00
-1,481.00
-1,750.00
-1,345.00
Cash Flow from Financing Activities
1,648.00
1,490.00
-840.00
-514.00
-1,287.00
-1,313.00
Net Cash Inflow / Outflow
-75.00
860.00
-483.00
214.00
124.00
-46.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
66.00
-9.00
57.00
24.00
50.00
12.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Japan Medical Dynamic Marketing, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
493.605
-587.388
1,080.00
184.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-776.019
142.119
-918.00
-646.03%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
205.554
-383.526
588.00
153.60%
Cash Flow from Investing Activities
-1995.847
57.94
-2,052.00
-3544.68%
Cash Flow from Financing Activities
1648.594
0
1,648.00
0.00%
Net Cash Inflow / Outflow
-75.291
-219.664
144.00
65.72%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
66.408
105.922
-39.00
-37.30%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -80.36% vs -50.28% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
205.55
1,046.63
-80.36%






